证券记录 · 已归档季度
INCY
Incyte Corporation · Healthcare · Biotechnology
24被追踪持有人
0Δ持有人
89.63M持有股份
$7.60B报告持仓市值
+0新建仓位
−1清仓
动量输入（同类管理人）： 持有人广度 0.0% · 股份流向 -2.2% · 净新建仓位 -4.2% · 公式
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | 0 | 433.49K | $48.73M | n/a | −2 |
| Q2 2026 | 154 | 0 | 131.73M | $14.93B | +4 | −5 |
| Q1 2026 | 158 | +1 | 132.61M | $12.47B | +5 | −5 |
| Q4 2025 | 156 | -1 | 139.13M | $13.74B | +1 | −1 |
| Q3 2025 | 24 | 0 | 89.63M | $7.60B | n/a | −1 |
| Q2 2025 | 22 | +1 | 88.20M | $6.01B | +1 | n/a |
| Q1 2025 | 18 | -1 | 44.33M | $2.68B | n/a | −1 |
| Q4 2024 | 19 | +1 | 43.85M | $3.03B | +1 | n/a |
| Q3 2024 | 17 | 0 | 35.50M | $2.35B | +1 | −1 |
| Q2 2024 | 17 | n/a | 33.47M | $2.03B | n/a | n/a |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (被动) | 19.95M | -0.9% | $1.69B | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 2 | BlackRock ✦ (被动) | 17.89M | -0.3% | $1.52B | 0.0% | ▼ Trim | 2 | SEC ↗ ×21 |
| 3 | Dodge & Cox ✦ | 13.93M | -4.5% | $1.18B | 0.6% | ▼ Trim | 6 | SEC ↗ |
| 4 | State Street Global Advisors ✦ (被动) | 9.68M | -2.0% | $820.69M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 5 | AQR Capital Management ✦ | 7.92M | -3.4% | $667.56M | 0.4% | ▼ Trim | 6 | SEC ↗ ×8 |
| 6 | Renaissance Technologies ✦ | 4.53M | +16.6% | $384.03M | 0.5% | ▲ Add | 6 | SEC ↗ |
| 7 | Geode Capital Management ✦ (被动) | 4.49M | +3.2% | $378.99M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 8 | Arrowstreet Capital ✦ | 3.10M | +13.7% | $263.25M | 0.2% | ▲ Add | 4 | SEC ↗ |
| 9 | Morgan Stanley ✦ | 2.64M | n/a | $223.96M | 0.0% | n/c | 1 | SEC ↗ ×13 |
| 10 | Goldman Sachs Group ✦ | 1.29M | n/a | $109.81M | 0.0% | n/c | 1 | SEC ↗ ×4 |
| 11 | Fidelity (FMR) ✦ | 1.27M | +10.0% | $107.88M | 0.0% | ▲ Add | 2 | SEC ↗ ×4 |
| 12 | JPMorgan Chase ✦ | 895.44K | n/a | $75.95M | 0.0% | n/c | 1 | SEC ↗ ×28 |
| 13 | T. Rowe Price ✦ | 781.35K | +238.6% | $66.27M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 14 | Point72 Asset Management ✦ | 477.07K | -51.6% | $40.46M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 15 | Gotham Asset Management ✦ | 234.43K | +24.8% | $19.88M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 16 | ARK Investment Management ✦ | 147.34K | -4.1% | $12.50M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 17 | Bridgewater Associates ✦ | 131.28K | -66.7% | $11.13M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 18 | D. E. Shaw & Co. ✦ | 63.77K | -84.3% | $5.41M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 19 | Two Sigma Investments ✦ | 48.15K | -25.2% | $4.08M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 20 | Millennium Management ✦ | 40.62K | -74.3% | $3.44M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 21 | Fisher Asset Management ✦ | 39.95K | +33.5% | $3.39M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 22 | Citadel Advisors ✦ | 33.84K | +847.7% | $2.87M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 23 | Wellington Management ✦ | 21.08K | -72.2% | $1.79M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 24 | Marshall Wace ✦ | 16.04K | -98.7% | $1.36M | 0.0% | ▼ Trim | 2 | SEC ↗ |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| 本季度无新增被追踪买入方。 |
已清仓
| Norges Bank | $96.78M | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 805 持有人, 201.47M 股份, $18.13B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Oct 15
CAGNONI PABLO J
Officer · 2.64K 股 · $297,780
Sep 15
CAGNONI PABLO J
Officer · 13.98K 股 · $1.69M
Sep 15
CAGNONI PABLO J
Officer · 9.23K 股 · $1.11M
Aug 19
CAGNONI PABLO J
Officer · 10.80K 股 · $1.36M
Aug 12
CAGNONI PABLO J
Officer · 10.80K 股 · $1.30M
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据